Evidence map›Paper›PMID 32187210›Full record

ArticlePloS one2020

Opportunistic screening for type 2 diabetes in community pharmacies. Results from a region-wide experience in Italy.

Roberto Gnavi, Veronica Sciannameo, Francesca Baratta, Cecilia Scarinzi, Marco Parente, Massimo Mana, Mario Giaccone, Paolo Cavallo Perin, Giuseppe Costa, Teresa Spadea and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Roberto GnaviEpidemiology Unit, ASL TO3, Grugliasco (TO), Italy.ORCID 0000-0003-1919-2199
Veronica SciannameoEpidemiology Unit, ASL TO3, Grugliasco (TO), Italy.
Francesca BarattaDepartment of Drug Science and Technology, University of Torino, Torino TO, Italy.
Cecilia ScarinziEpidemiology Unit, ASL TO3, Grugliasco (TO), Italy.
Marco ParenteDepartment of Drug Science and Technology, University of Torino, Torino TO, Italy.
Massimo ManaATF Informatics, Cuneo, Italy.
Mario GiacconeOrder of Pharmacists of Torino, Torino TO, Italy.
Paolo Cavallo PerinDepartment of Medical Sciences, University of Torino, Torino TO, Italy.
Giuseppe CostaEpidemiology Unit, ASL TO3, Grugliasco (TO), Italy.
Teresa SpadeaEpidemiology Unit, ASL TO3, Grugliasco (TO), Italy.
Paola BrusaDepartment of Drug Science and Technology, University of Torino, Torino TO, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aimsGiven the paucity of symptoms in the early stages of type 2 diabetes, its diagnosis is often made when complications have already arisen. Although systematic population-based screening is not recommended, there is room to experience new strategies for improving early diagnosis of the disease in high risk subjects. We report the results of an opportunistic screening for diabetes, implemented in the setting of community pharmacies. METHODS AND

resultsTo identify people at high risk to develop diabetes, pharmacists were trained to administer FINDRISC questionnaire to overweight, diabetes-free customers aged 45 or more. Each interviewee was followed for 365 days, searching in the administrative database whether he/she had a glycaemic or HbA1c test, or a diabetologists consultation, and to detect any new diagnosis of diabetes defined by either a prescription of any anti-hyperglycaemic drug, or the enrolment in the register of patients, or a hospital discharge with a diagnosis of diabetes. Out of 5977 interviewees, 53% were at risk of developing diabetes. An elevated FINDRISC score was associated with higher age, lower education, and living alone. Excluding the number of cases expected, based on the incidence rate of diabetes in the population, 51 new cases were identified, one every 117 interviews. FINDRISC score, being a male and living alone were significantly associated with the diagnosis.

conclusionsThe implementation of a community pharmacy-based screening programme can contribute to reduce the burden of the disease, particularly focusing on people at higher risk, such as the elderly and the socially vulnerable.

Indexed as

Community Pharmacy ServicesBlood GlucoseDatabases, FactualDiabetes Mellitus, Type 2FemaleHumansItalyMaleMass ScreeningMiddle AgedOverweightPharmaciesSurveys and QuestionnairesBlood Glucose

Identifiers

PMID32187210
PMCPMC7080237
OpenAlexW3011868805

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.